About the EU-ToxRisk Project 

Edelweiss Connect is one of 39 partners in EU-ToxRisk – An Integrated European ‘Flagship’ Programme Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st century.

It integrates advancements in cell biology, omics technologies, systems biology and computational modelling to define the complex chains of events that link chemical exposure to toxic outcome. Our tasks are: the development of a knowledge infrastructure facilitating easy sharing of scientific information and results within the scientific community; advanced modelling to support the EU-ToxRisk case studies including the development of quantitative adverse outcome pathways; and working on the regulatory acceptance and commercialization of the project results.

These are performed in cooperation with our main partners EMBL-EBI, TNO and Universtät Wien as well as Fraunhofer ITEM, Universität Konstanz and BioDetection Systems.

EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

The EU-ToxRisk Commercial Partnership is a joint venture between organisations providing coordinated integrated solutions to industrial problems in safety assessment. The partners bring experience and resources together to provide a one-stop shop in safety assessment solutions.

We jointly have experience in New Approach Methodology in safety assessment, predictive toxicology, in vitro screening, computational modelling, toxicogenomics, read across, tiered strategies, data science, product design, risk assessment and regulatory assessment.